Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | POLA1 | P09884 | 1/20 | 0.38 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.33 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | P2RY1 | P47900 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9913499 | 0.89 | KDM4E (0.59) | KDM4EPOLA1TAS1R3TAS1R1POLB | |
| SCHEMBL25505327 | 0.89 | KDM4E (0.59) | KDM4EPOLA1TAS1R3TAS1R1POLB | |
| SCHEMBL25504740 | 0.84 | KDM4E (0.66) | KDM4EPOLA1TAS1R3TAS1R1POLB | |
| SCHEMBL3278946 | 0.82 | KDM4E (0.48) | KDM4EPOLA1POLB | |
| SCHEMBL12017695 | 0.80 | KDM4E (0.54) | KDM4EPOLA1TAS1R3TAS1R1POLB | |
| SCHEMBL21620265 | 0.78 | KDM4E (0.43) | KDM4EPOLA1TAS1R3TAS1R1POLB | |
| SCHEMBL24102841 | 0.77 | KDM4E (0.54) | KDM4EPOLA1TAS1R3TAS1R1POLB | |
| SCHEMBL23898886 | 0.77 | KDM4E (0.54) | KDM4EPOLA1TAS1R3TAS1R1POLB | |
| SCHEMBL9608777 | 0.77 | POLA1 (0.57) | KDM4EPOLA1TAS1R3TAS1R1POLB | |
| SCHEMBL25504673 | 0.77 | POLA1 (0.57) | KDM4EPOLA1TAS1R3TAS1R1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230159922-A1 | MODIFIED OLIGOMERIC COMPOUNDS AND USES THEREOF | IONIS PHARMACEUTICALS, INC. (US) | 2023-05-25 | — | — | US | disclosed |